Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Europe (Supplemental) | 2017 | Market Analysis

The European market for heart valve devices will grow through 2025 as a result of rising adoption of THV devices; in particular, improvements to TAVR devices and emerging TMVR devices will drive cannibalization of surgical procedures.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the heart valve device market in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Europe
The European TEO device market is projected to experience modest growth over the forecast period, driven by increasing adoption of minimally invasive procedures. The trend is further supported by…